Researchers
Nikolić, Katarina
Type
- 214 Conference Paper
- 182 Article
- 3 Text book
- 2 Book parts
- 2 Other
- 1 Reviews
Date issued
- 372 2000 - 2027
- 32 1901 - 1999
Results 81-100 of 404
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Application of computational methods in rational design of multi-target ligands as potential antipsychotics and antidepressants | Radan, Milica   ; Đikić, Teodora ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions | Milović Emilija ; Petronijević Jelena ; Joksimović Nenad ; Beljkaš M. ; Ružić D. ; Nikoletić Katarina ; Vraneš Milan ; Tot Aleksandar S. ; Đorđić Crnogorac Marija ; Stanojković Tatjana P. ;
Janković Nenad
; | Article | 22M22 |
| 2022 | Development and validation of UHPLC-MS/MS method for analysis of ziprasidone and its impurities | Čarapić, Marija; Marković, Bojan ; Nikolić, Katarina ; Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2022 | Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaign | Đoković, Nemanja ; Ružić, Dušan ; Rahnasto‐Rilla, Minna; Srdić-Rajić, Tatjana ; Lahtela‐Kakkonen, Maija; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies | Milica Radan ; Teodora Djikic; Katarina Nikolic | Article | 21M21 |
| 2022 | Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies | Bon, Corentin; Barbachowska, Magdalena; Đoković, Nemanja ; Ružić, Dušan ; Si, Yang; Soresinetti, Laura; Jallet, Corinne; Tafit, Ambre; Halby, Ludovic; Nikolić, Katarina ;
Arimondo, Paola B;
| Article | 21M21 |
| 2022 | Identification of novel 1-benzhydryl-piperazine derivatives as Histone Deacetylase inhibitors using Fragment-based drug design strategy | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Ganesan, A.; Pavić, Aleksandar; Srdić Rajić, Tatjana ; Petković, Miloš ; Nikolić, Katarina | Other | Mp. category will be shown later |
| 2022 | Investigation of retention characteristics and an unknown degradant of ziprasidone, antipsychotic with unique profile binding for GPCRs receptor | Čarapić, Marija; Nikolić, Katarina ; Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2022 | Computer-aided drug design and evaluation of selective inhibitors against cytoplasmic histone deacetylases | Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | The ANN-QSRR modeling of chromatographic properties of ziprasidone and its impurities | Čarapić, Marija; Nikolić, Katarina ; Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2022 | Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Gul, Sheraz; Beljkaš, Milan ; Đurić, Ana ; Ganesan, Arasu; Pavić, Aleksandar ; Srdić-Rajić, Tatjana ;
Petković, Miloš
; Nikolić, Katarina ; | Article | 21aM21a |
| 2022 | The ionization of pharmacologically active compounds in the presence of differently charged micelles as biomembrane mimetic systems | Popović-Nikolić, Marija ; Nikolić, Katarina ; Popović, Gordana | Conference Paper | Mp. category will be shown later |
| 2022 | Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells | Bulut, Ipek; Lee, Adam; Cevatemre, Buse; Ružić, Dušan ; Belle, Roman; Kawamura, Akane; Gul, Sheraz; Nikolić, Katarina ; Ganesan, A.; Acilan, Ceyda | Article | 21M21 |
| 2022 | Adrenergici, antianginalni lekovi i vazodilatatori | Nikolić, Katarina M. | Text book | Mp. category will be shown later |
| 2022 | Characterisation of novel impurity of ziprasidone with NMR spectroscopy and UPLC-MS/MS | Čarapić, Marija; Marković, Bojan ; Petković, Miloš ; Nikolić, Katarina ; Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2022 | Characterization of unknown degradant of ziprasidone with NMR spetroscopy | Čarapić, Marija; Petković, Miloš ; Marković, Bojan ; Popović-Nikolić, Marija ; Agbaba, Danica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Design of novel dual COX 2 and 5 LOX inhibitors using quantitative structure activity relationships analysis | Bošković, Jelena ; Dobričić, Vladimir ; Ružić, Dušan ; Nikolić, Katarina ; Čudina, Olivera | Conference Paper | Mp. category will be shown later |
| 2021 | Current computer-aided drug design methodologies in discovery of novel drug candidates for neuropsychiatric and inflammatory diseases | Radan, Milica ; Bošković, Jelena ; Dobričić, Vladimir ; Čudina, Olivera ; Nikolić, Katarina | Article | 52M52 |
| 2021 | Design of dual cyclooxygenase-2 and 5-lipoxygenase inhibitors with iron-chelating properties – molecular docking | Bošković, Jelena ; Ružić, Dušan ; Čudina, Olivera ; Nikolić, Katarina ; Dobričić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2021 | In silico drug repurposing of small organic molecules and peptide ligands for GPR56 receptor | Senćanski, Milan ; Glišić, Sanja ; Nikolić, Katarina M. ; Đikić, Teodora | Conference Paper | Mp. category will be shown later |